Biosimilars | Association for Accessible Medicines


Christine Simmon: GRx+Biosims Combines Three Events into One

Christine Simmon, AAM Senior Vice President of Policy and Strategic Alliances and Executive Director of the Biosimilars Council, invites industry professionals to attend GRx+Biosims 2018 on Sept. 5-7 in Baltimore, MD. This year, we are combining FallTech, Leading on Biosimilars, and CMC Workshop to one can't-miss opportunity to connect with peers around the world. Attend GRx+Biosims to hear the latest from top-in-their-field speakers and government officials, share best practices and discover new learning tracks in the generic and biosimilars industry.

The Biosimilars Council Congressional Briefing: Five Takeaways

Last Friday, The Biosimilars Council hosted a congressional briefing titled “Biosimilars: The Challenges and Promise of Patient Access.” AAM’s Craig Burton moderated a discussion with Molly Burich (Boehringer Ingelheim), Mark Fleury (American Cancer Society’s Cancer Action Network), Greg Gierer (America’s Health Insurance Plans) and Patrick Vallano (Mylan).

Biosimilars Handbook

The New Frontier for Improved Access to Medicines: Biosimilars & Interchangeable Biologic Products

Biosimilars hold the key to ensuring affordable access to biologic medicines for all consumers. The Biosimilars Council exists to educate, advocate, and promote the development of these products through resources such as this handbook.

This handbook is designed to be a reference tool for health care professionals as well as patients interested in learning more about biosimilars and interchangeable biologics. 

Subscribe to Biosimilars

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.